biotin and Cirrhosis
biotin has been researched along with Cirrhosis in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| An, XF; Chen, C; Chen, MM; Jiang, H; Liu, HL; Si, ZL; Su, K; Tan, NH; Vaziri, ND; Wang, LX; Wu, WH; Zhang, ZH; Zhou, W | 1 |
| Cau, J; Giraud, S; Goujon, JM; Hauet, T; Joffrion, S; Kerforne, T; Mauco, G; Petitou, M; Saint-Yves, T; Tillet, S | 1 |
| Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE | 1 |
Other Studies
3 other study(ies) available for biotin and Cirrhosis
| Article | Year |
|---|---|
Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho.
Topics: Adenine; Animals; Artemisinins; Azacitidine; beta Catenin; Biotin; DNA; DNA Modification Methylases; Fibrosis; Glucuronidase; HEK293 Cells; Humans; Kidney; Klotho Proteins; Mice; Proteasome Endopeptidase Complex; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ubiquitins; Ureteral Obstruction | 2022 |
Inhibition of coagulation proteases Xa and IIa decreases ischemia-reperfusion injuries in a preclinical renal transplantation model.
Topics: Animals; Biomarkers; Biotin; Blood Coagulation; Cold Temperature; Endothelial Cells; Epithelial-Mesenchymal Transition; Factor Xa; Factor Xa Inhibitors; Fibrosis; Humans; Hypoxia; Inflammation; Kidney; Kidney Function Tests; Kidney Transplantation; Leukocytes; Models, Animal; Oligosaccharides; Prothrombin; Reperfusion Injury; Sus scrofa; Thrombin | 2016 |
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling | 1998 |